Treeline Biosciences Stock

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Sign up today and learn more about Treeline Biosciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Treeline Biosciences Stock

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions. The company was founded in 2021 and is headquartered in Stamford, Connecticut.

Funding History

April 2021$212M
October 2022$261M

Management

SVP Corporate Development

Spencer Smith

CEO & Co-Founder

Josh Bilenker

Co-Founder & CSO

Jeffrey Engelman

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo